Artiva Biotherapeutics, Inc. (ARTV)
10.22
-0.20
(-1.92%)
USD |
NASDAQ |
Sep 11, 16:00
10.23
+0.01
(+0.10%)
After-Hours: 20:00
Artiva Biotherapeutics Shareholders Equity (Quarterly) : 347.50M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 347.50M |
| March 31, 2026 | 87.85M |
| December 31, 2025 | 109.97M |
| September 30, 2025 | 129.22M |
| June 30, 2025 | 149.04M |
| March 31, 2025 | 168.78M |
| December 31, 2024 | 186.64M |
| September 30, 2024 | 201.00M |
| June 30, 2024 | 25.32M |
| March 31, 2024 | 41.74M |
| December 31, 2023 | 54.40M |
| September 30, 2023 |
| Date | Value |
|---|---|
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | 117.00M |
| December 31, 2021 | 127.56M |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | -21.57M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Climb Bio, Inc. | 239.55M |
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.528B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 368.63M |
| Total Liabilities (Quarterly) | 21.13M |
| Debt to Equity Ratio | 0.0283 |
| Current Ratio | 24.16 |
| Net Debt Paydown Yield | 0.18% |